1. Home
  2. RPRX vs FTI Comparison

RPRX vs FTI Comparison

Compare RPRX & FTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RPRX
  • FTI
  • Stock Information
  • Founded
  • RPRX 1996
  • FTI 1884
  • Country
  • RPRX United States
  • FTI United States
  • Employees
  • RPRX N/A
  • FTI N/A
  • Industry
  • RPRX Biotechnology: Pharmaceutical Preparations
  • FTI Metal Fabrications
  • Sector
  • RPRX Health Care
  • FTI Industrials
  • Exchange
  • RPRX Nasdaq
  • FTI Nasdaq
  • Market Cap
  • RPRX 11.7B
  • FTI 12.7B
  • IPO Year
  • RPRX 2020
  • FTI N/A
  • Fundamental
  • Price
  • RPRX $25.23
  • FTI $29.09
  • Analyst Decision
  • RPRX Strong Buy
  • FTI Strong Buy
  • Analyst Count
  • RPRX 6
  • FTI 12
  • Target Price
  • RPRX $41.67
  • FTI $35.09
  • AVG Volume (30 Days)
  • RPRX 3.2M
  • FTI 3.9M
  • Earning Date
  • RPRX 02-13-2025
  • FTI 02-20-2025
  • Dividend Yield
  • RPRX 3.33%
  • FTI 0.69%
  • EPS Growth
  • RPRX 518.56
  • FTI N/A
  • EPS
  • RPRX 2.55
  • FTI 1.43
  • Revenue
  • RPRX $2,266,003,000.00
  • FTI $8,796,600,000.00
  • Revenue This Year
  • RPRX $12.21
  • FTI $16.26
  • Revenue Next Year
  • RPRX $11.13
  • FTI $9.81
  • P/E Ratio
  • RPRX $9.88
  • FTI $20.29
  • Revenue Growth
  • RPRX N/A
  • FTI 17.82
  • 52 Week Low
  • RPRX $24.05
  • FTI $18.33
  • 52 Week High
  • RPRX $31.66
  • FTI $32.64
  • Technical
  • Relative Strength Index (RSI)
  • RPRX 43.88
  • FTI 44.76
  • Support Level
  • RPRX $24.05
  • FTI $28.36
  • Resistance Level
  • RPRX $25.28
  • FTI $31.09
  • Average True Range (ATR)
  • RPRX 0.55
  • FTI 0.95
  • MACD
  • RPRX 0.00
  • FTI -0.36
  • Stochastic Oscillator
  • RPRX 46.46
  • FTI 17.06

About RPRX Royalty Pharma plc

Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products, including AbbVie and Johnson & Johnson's Imbruvica (for chronic lymphocytic leukemia and other blood cancers), Biogen's Tysabri (for relapsing forms of multiple sclerosis), Vertex's cystic fibrosis franchise, and 10 development-stage product candidates.

About FTI TechnipFMC plc

TechnipFMC is the largest pure-play offshore oilfield service provider, offering integrated deep-water offshore oil and gas development solutions that span the full spectrum of subsea equipment and subsea engineering and construction services. The company also provides various surface equipment used with onshore oil and gas wells. TechnipFMC originated with the 2017 merger of predecessor companies Technip and FMC Technologies.

Share on Social Networks: